We are live on ! Find out more
KFS

Kurt F. Somerville Portfolio holdings

AUM $379M
1-Year Est. Return 19.42%
This Fund
S&P 500
This Quarter Est. Return
+5.24%
1 Year Est. Return
+19.42%
3 Year Est. Return
+62.7%
5 Year Est. Return
+83.65%
10 Year Est. Return
+302.17%
AUM
$402M
AUM Growth
+$154M
Cap. Flow
+$140M
Cap. Flow %
34.96%
Top 10 Hldgs %
34.66%
Holding
133
New
31
Increased
71
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$5.69M
2
MA icon
Mastercard
MA
+$5.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$4.68M
4
CNI icon
Canadian National Railway
CNI
+$4.64M
5
NVS icon
Novartis
NVS
+$4.59M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$1.02M
2
XEC
CIMAREX ENERGY CO
XEC
+$214K
3
HUB.B
HUBBELL INC CL-B
HUB.B
+$202K
4
GLW icon
Corning
GLW
+$152K
5
GILD icon
Gilead Sciences
GILD
+$20.7K

Sector Composition

Rank Sector Weight
1 Technology 24.12%
2 Healthcare 21.83%
3 Industrials 18.28%
4 Energy 9.56%
5 Consumer Staples 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
51
Pfizer
PFE
$144B
$1.49M 0.37%
50,550
+7,431
+17% +$213K
COP icon
52
ConocoPhillips
COP
$139B
$1.34M 0.33%
19,366
ALNY icon
53
Alnylam Pharmaceuticals
ALNY
$38.5B
$1.29M 0.32%
13,282
+6,965
+110% +$645K
WMT icon
54
Walmart Inc
WMT
$900B
$1.21M 0.3%
42,195
+22,695
+116% +$613K
DD
55
DELISTED
Du Pont De Nemours E I
DD
$1.2M 0.3%
17,043
UNFI icon
56
United Natural Foods
UNFI
$3.07B
$1.15M 0.29%
+14,922
New +$1.05M
BRK.A icon
57
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.13M 0.28%
5
+2
+67% +$433K
VWO icon
58
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$1.13M 0.28%
+28,125
New +$1.16M
BRK.B icon
59
Berkshire Hathaway Class B
BRK.B
$1.11T
$1.12M 0.28%
7,448
+3,850
+107% +$556K
NSC icon
60
Norfolk Southern
NSC
$76.1B
$1.12M 0.28%
10,200
WFC icon
61
Wells Fargo
WFC
$263B
$942K 0.23%
17,200
+10,300
+149% +$545K
D icon
62
Dominion Energy
D
$62.1B
$923K 0.23%
12,000
MON
63
DELISTED
Monsanto Co
MON
$913K 0.23%
7,638
+1,583
+26% +$184K
CB
64
DELISTED
CHUBB CORPORATION
CB
$887K 0.22%
8,574
BMY icon
65
Bristol-Myers Squibb
BMY
$130B
$880K 0.22%
14,900
+5,700
+62% +$321K
KO icon
66
Coca-Cola
KO
$380B
$860K 0.21%
20,356
+2,106
+12% +$89.9K
SJM icon
67
J.M. Smucker
SJM
$13.2B
$829K 0.21%
8,215
+3,060
+59% +$310K
STKL
68
DELISTED
SunOpta
STKL
$749K 0.19%
63,175
+47,275
+297% +$592K
ECL icon
69
Ecolab
ECL
$79.6B
$695K 0.17%
6,650
NGG icon
70
National Grid
NGG
$81.3B
$658K 0.16%
9,640
+1,037
+12% +$72.1K
NVO
71
Novo Nordisk
NVO
$225B
$651K 0.16%
30,800
-50
-0.2% -$1.12K
HES
72
DELISTED
Hess
HES
$600K 0.15%
8,130
AXP icon
73
American Express
AXP
$227B
$598K 0.15%
6,430
+1,430
+29% +$128K
IVV icon
74
iShares Core S&P 500 ETF
IVV
$871B
$578K 0.14%
2,796
+1,398
+100% +$283K
GILD icon
75
Gilead Sciences
GILD
$167B
$575K 0.14%
6,100
-200
-3% -$20.7K

Similar funds

Kurt F. Somerville's Q4 2014 Portfolio in Review

As of Q4 2014, Kurt F. Somerville held 133 positions worth $402M, up 62% from $248M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Kurt F. Somerville deployed $140M of net new capital in Q4 2014, opening 31 new positions and adding to 71 existing holdings. Its largest new stake was CDK Global, Inc.: 46,231 shares worth $1.89M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was GSK, an estimated $1.02M trimmed.

  • Kurt F. Somerville's largest Q4 2014 buy was CDK Global, Inc.: 46,231 shares worth $1.89M.
  • Kurt F. Somerville added most to CVS Health in Q4 2014, an estimated $5.69M increase.
  • Kurt F. Somerville's biggest Q4 2014 reduction was GSK, cutting an estimated $1.02M.
  • Kurt F. Somerville fully exited CIMAREX ENERGY CO in Q4 2014, selling an estimated $214K.
  • Kurt F. Somerville's ten largest holdings make up 35% of its $402M portfolio in Q4 2014.
  • Kurt F. Somerville opened 31 new positions and closed 3 in Q4 2014.
  • Kurt F. Somerville's portfolio value rose 62% quarter-over-quarter to $402M.

Based on Kurt F. Somerville's 13F filing for Q4 2014, filed 13 Feb 2015.